Abstract
The organoruthenium complex [(η6-hmb)Ru(en)(Cl)][PF6] (hmb is hexamethylbenzene, en is ethylenediamine) undergoes facile aquation and then reacts with KSCN in unbuffered solution to give the S-coordinated thiocyanato product [(η6-hmb)Ru(en)(S-SCN)]+ which slowly converts to the thermodynamically favored N-bound complex [(η6-hmb)Ru(en)(N-NCS)]+ (1 +). Complex 1 was synthesized and characterized by X-ray crystallography and mass spectrometry. Despite its lack of hydrolysis over 24 h, complex 1 exhibits moderate cytotoxicity (IC50 24 μM) towards the human ovarian cancer cell line A2780, comparable with that of the chlorido analogue which is thought to be activated (towards potential target DNA) via a rapid aquation (Wang et. al. in Proc Natl Acad Sci USA 102:18269–18274, 2005). Detailed kinetic studies suggest that complex 1 binds to guanosine 5′-monophosphate (GMP) through direct N7 substitution of the N-bound SCN ligand. In the presence of a high concentration of chloride (104 mM), however, complex 1 may bind partly to GMP via Cl substitution.
Similar content being viewed by others
References
Alessio E, Mestroni G, Bergamo A, Sava G (2004) Ruthenium anticancer drugs. Metal complexes in tumor diagnosis and as anticancer agents. Metal Ions Biol Syst 42:323–351
Bruijnincx PCA, Sadler PJ (2008) Curr Opin Chem Biol 12:197–206
Clarke MJ (2003) Coord Chem Rev 236:209–233
Hambley TW (2007) Science 318:1392–1393
Reedijk J (1999) Curr Opin Chem Biol 3:236–240
Wang FY, Habtemariam A, van der Geer EPL, Fernandez R, Melchart M, Deeth RJ, Aird R, Guichard S, Fabbiani FPA, Lozano-Casal P, Oswald IDH, Jodrell DI, Parsons S, Sadler PJ (2005) Proc Natl Acad Sci USA 102:18269–18274
Clarke MJ, Stubbs M (1996) Interactions of metallopharmaceuticals with DNA. Metal Ions Biol Syst 32:727–780
Clarke MJ, Zhu FC, Frasca DR (1999) Chem Rev 99:2511–2533
Frasca DR, Clarke MJ (1999) J Am Chem Soc 121:8523–8532
Alessio E, Mestroni G, Bergamo A, Sava G (2004) Curr Top Med Chem 4:1525–1535
Jakupec MA, Galanski M, Arion VB, Hartinger CG, Keppler BK (2008) Dalton Trans 183–194
Aird RE, Cummings J, Ritchie AA, Muir M, Morris RE, Chen H, Sadler PJ, Jodrell DI (2002) Br J Cancer 86:1652–1657
Yan YK, Melchart M, Habtemariam A, Sadler PJ (2005) Chem Commun 4764–4776
Wang FY, Aird RE, Habtemarian H, Jodrell DI, Sadler PJ, Guichard SM (unpublished data)
Novakova O, Kasparkova J, Bursova V, Hofr C, Vojtiskova M, Chen HM, Sadler PJ, Brabec V (2005) Chem Biol 12:121–129
Chen HM, Parkinson JA, Parsons S, Coxall RA, Gould RO, Sadler PJ (2002) J Am Chem Soc 124:3064–3082
Chen HM, Parkinson JA, Morris RE, Sadler PJ (2003) J Am Chem Soc 125:173–186
Sheldrick GM (1998) SADAB. Program for carrying-out multiscan absorption corrections. University of Göttingen, Germany
Wang FY, Xu JJ, Habtemariam A, Bella J, Sadler PJ (2005) J Am Chem Soc 127:17734–17743
Morris RE, Aird RE, Murdoch Pdel S, Chen H, Cummings J, Hughes ND, Parsons S, Parkin A, Boyd G, Jodrell DI, Sadler PJ (2001) J Med Chem 44:3616–3621
Wang FY, Chen HM, Parsons S, Oswald LDH, Davidson JE, Sadler PJ (2003) Chem Eur J 9:5810–5820
Chen HM, Parkinson JA, Novakova O, Bella J, Wang FY, Dawson A, Gould R, Parsons S, Brabec V, Sadler PJ (2003) Proc Natl Acad Sci USA 100:14623–14628
Novakova O, Chen HM, Vrana O, Rodger A, Sadler PJ, Brabec V (2003) Biochemistry 42:11544–11554
Hamaguchi T, Ujimoto K, Ando I (2007) Inorg Chem 46:10455–10457
Homanen P, Haukka M, Pakkanen TA, Pursiainen J, Laitinen RH (1996) Organometallics 15:4081–4084
Kohle O, Gratzel M, Meyer AF, Meyer TB (1997) Adv Mater 9:904–906
Kohle O, Ruile S, Gratzel M (1996) Inorg Chem 35:4779–4787
Nazeeruddin MK, Pechy P, Renouard T, Zakeeruddin SM, Humphry-Baker R, Comte P, Liska P, Cevey L, Costa E, Shklover V, Spiccia L, Deacon GB, Bignozzi CA, Gratzel M (2001) J Am Chem Soc 123:1613–1624
Nazeeruddin MK, Zakeeruddin SM, Humphry-Baker R, Jirousek M, Liska P, Vlachopoulos N, Shklover V, Fischer CH, Gratzel M (1999) Inorg Chem 38:6298–6305
Brito RMC, Batista AA, Ellena J, Castellano EE, Diogenes ICN, Lopes LGD, de Sousa JR, Moreira ID (2007) Inorg Chem Commun 10:1515–1517
Nagao H, Ooyama D, Hirano T, Naoi H, Shimada M, Sasaki S, Nagao N, Mukaida M, Oi T (2001) Inorg Chim Acta 320:60–66
Tabatabaeian K, Adams H, Mann BE, White C (2003) J Organomet Chem 688:75–81
Steed JW, Tocher DA (1992) J Chem Soc Dalton Trans 459–461
Venter GJS, Meijboom R, Roodt A (2007) Acta Crystallogr Sect E Struct Rep Online 63:M3076–U1962
Toma HE, Santos PS, Mattioli MPD, Oliveira LAA (1987) Polyhedron 6:603–611
Bajaj HC, Das A, van Eldik R (1998) J Chem Soc Dalton Trans 1563–1568
Matsubara T, Creutz C (1979) Inorg Chem 18:1956–1966
Vandenburgh L, Buck MR, Freedman DA (2008) Inorg Chem 47:9134–9136
Wang FY, Zeitlin BD, Eades L, Jodrell DI, Sadler PJ (unpublished data)
Acknowledgments
We thank Oncosense Ltd and the Chinese Academy of Sciences (Hundred Talents Programme) for their support for this work, and Emily Jones (Oncosense) for measuring the IC50 of complex 1. We also thank members of EC COST Action D39 for stimulating discussions.
Author information
Authors and Affiliations
Corresponding authors
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Wang, F., Habtemariam, A., van der Geer, E.P.L. et al. Synthesis, characterization, and reaction pathways for the formation of a GMP adduct of a cytotoxic thiocyanato ruthenium arene complex. J Biol Inorg Chem 14, 1065–1076 (2009). https://doi.org/10.1007/s00775-009-0549-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-009-0549-x